Drivers of Job Loss Among Chinese Breast Cancer Survivors: A Qualitative Analysis
Psycho-Oncology · 2025
DOI: 10.1002/pon.70122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Susan Chimonas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, East Asian People, Employment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Cancer Society, National Institutes of Health/National Cancer Institute.
Abstract (Originalsprache)
Purpose
This study aimed to understand the reasons for the high risk of job loss previously identified among foreign‐born Chinese breast cancer survivors in the United States Qualitative interviews were conducted to explore challenges leading to job loss during/after treatment and to help identify potential interventions to promote job retention and re‐employment. Patients and Methods The research team conducted semi‐structured interviews with foreign‐born Chinese breast cancer survivors in New York City. A total of 12 participants, previously enrolled in the Breast Cancer and the Workforce study, were interviewed between February and November 2018. Purposive sampling was used to identify participants diverse across job type and work history. Thematic content analysis was conducted on translated interview transcripts.
Results
Since diagnosis, 8/12 participants had experienced job loss (6/6 in service/production, 1/5 retail/administrative, and 1/1 professional/managerial). Many described being unable to work due to treatment side‐effects, inflexible schedules, and a perception that work accommodations were unavailable. Only one participant who had lost her job went on to secure stable re‐employment.
Conclusions
Job type, language barriers, and cultural attitudes towards work accommodations contributed to a high job‐loss rate in this population. Those who remained employed had received work accommodations. Lack of awareness or belief in obtaining accommodations was a critical factor in job loss. Implications for Cancer Survivors These findings highlight the necessity of advocacy for work accommodations for cancer patients and culturally competent care. Addressing these issues could improve job retention and financial stability for breast cancer survivors, particularly among immigrant and minority groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Bryn Mawr College, Bryn Mawr, Pennsylvania, USA.
- Weill Cornell Medicine, New York, New York, USA.
ORCID-Profile: Yashasvini Sampathkumar
Förderung
- NCI NIH HHS
- American Cancer Society
- National Institutes of Health/National Cancer Institute
- CCNY/MSKCC Partnership for Cancer Research Training and Community Outreach
- American Society of Clinical Oncology
- Chanel Endowment for Survivorship Research at Memorial Sloan Kettering Cancer Center
- National Cancer Institute
Zitieren
APA
Chimonas, S., Sampathkumar, Y., Huang, X., Tran, C., Wang, Z., Kuo, T. T., Rosenberg, S. M., González, J., Gany, F., & Blinder, V. (2025). Drivers of Job Loss Among Chinese Breast Cancer Survivors: A Qualitative Analysis. Psycho-Oncology. https://doi.org/10.1002/pon.70122
Vancouver
Chimonas S, Sampathkumar Y, Huang X, Tran C, Wang Z, Kuo TT, et al. Drivers of Job Loss Among Chinese Breast Cancer Survivors: A Qualitative Analysis. Psycho-Oncology. 2025. doi:10.1002/pon.70122
BibTeX
@article{Chimonas2025,
author = {Chimonas, Susan and Sampathkumar, Yashasvini and Huang, Xiaoxiao and Tran, Christina and Wang, Zhenlan and Kuo, Ting-Ting and Rosenberg, Shoshana M and González, Javier and Gany, Francesca and Blinder, Victoria},
title = {Drivers of Job Loss Among Chinese Breast Cancer Survivors: A Qualitative Analysis},
journal = {Psycho-Oncology},
year = {2025},
doi = {10.1002/pon.70122}
}
EUVIMED